Hawley C - Search Results

1

Response to article by Caponi et al. about serum free light chains.

Tate JR, Hawley C, Mollee P. Tate JR, et al. Among authors: hawley c. Clin Chem Lab Med. 2018 Dec 19;57(2):e1-e2. doi: 10.1515/cclm-2018-0994. Clin Chem Lab Med. 2018. PMID: 30267629 No abstract available.

2

High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease.

Mutsando H, Fahim M, Gill DS, Hawley CM, Johnson DW, Gandhi MK, Marlton PV, Fan HG, Mollee PN. Mutsando H, et al. Am J Blood Res. 2012;2(1):66-70. Epub 2012 Jan 1. Am J Blood Res. 2012. PMID: 22432089 Free PMC article.

3

Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.

Taylor E, Jones M, Hourigan MJ, Johnson DW, Gill DS, Isbel N, Hawley CM, Marlton P, Gandhi MK, Campbell SB, Mollee P. Taylor E, et al. Nephrol Dial Transplant. 2015 Oct;30(10):1774-9. doi: 10.1093/ndt/gfv260. Epub 2015 Jul 18. Nephrol Dial Transplant. 2015. PMID: 26188340

4

Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.

Kennard A, Hawley C, Tate J, Klingberg S, Pretorius C, Hutchison C, Mollee P. Kennard A, et al. Among authors: hawley c. Clin Chem Lab Med. 2016 Jun 1;54(6):1045-52. doi: 10.1515/cclm-2015-0799. Clin Chem Lab Med. 2016. PMID: 26684350

5

Design and methods of the REMOVAL-HD study: a tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients.

Krishnasamy R, Hawley CM, Jardine MJ, Roberts MA, Cho YJ, Wong MG, Heath A, Nelson CL, Sen S, Mount PF, Pascoe EM, Darssan D, Vergara LA, Paul-Brent PA, Toussaint ND, Johnson DW, Hutchison CA. Krishnasamy R, et al. Among authors: hawley cm. BMC Nephrol. 2018 Apr 17;19(1):89. doi: 10.1186/s12882-018-0883-8. BMC Nephrol. 2018. PMID: 29665795 Free PMC article.

6

A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.

Krishnasamy R, Hawley CM, Jardine MJ, Roberts MA, Cho Y, Wong M, Heath A, Nelson CL, Sen S, Mount PF, Pascoe EM, Vergara LA, Paul-Brent PA, Toussaint ND, Johnson DW, Hutchison CA. Krishnasamy R, et al. Blood Purif. 2020;49(4):468-478. doi: 10.1159/000505567. Epub 2020 Jan 22. Blood Purif. 2020. PMID: 31968346

7

Review Article: is it time to embrace haemodiafiltration for centre-based haemodialysis?

Petrie JJ, Ng TG, Hawley CM. Petrie JJ, et al. Nephrology (Carlton). 2008 Jun;13(4):269-77. doi: 10.1111/j.1440-1797.2008.00964.x. Nephrology (Carlton). 2008. PMID: 18476914 Review.

8

Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.

McIntyre HD, Menzies B, Rigby R, Perry-Keene DA, Hawley CM, Hardie IR. McIntyre HD, et al. Among authors: hawley cm. Clin Transplant. 1995 Feb;9(1):20-4. Clin Transplant. 1995. PMID: 7742578 Clinical Trial.

9

Effect of OKT3 in steroid-resistant renal transplant rejection.

Petrie JJ, Rigby RJ, Hawley CM, Suranyi MG, Whitby M, Wall D, Hardie IR. Petrie JJ, et al. Among authors: hawley cm. Transplantation. 1995 Feb 15;59(3):347-52. Transplantation. 1995. PMID: 7871563 Clinical Trial.

10

Sclerosing peritonitis: identification of diagnostic, clinical, and radiological features.

Campbell S, Clarke P, Hawley C, Wigan M, Kerlin P, Butler J, Wall D. Campbell S, et al. Among authors: hawley c. Am J Kidney Dis. 1994 Nov;24(5):819-25. doi: 10.1016/s0272-6386(12)80677-9. Am J Kidney Dis. 1994. PMID: 7977325

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

701 results

Search Page